Pliant Therapeutics Inc (PLRX)
12.98
+0.13
(+1.01%)
USD |
NASDAQ |
Nov 22, 16:00
12.99
+0.01
(+0.08%)
After-Hours: 20:00
Pliant Therapeutics Shareholders Equity (Quarterly): 345.82M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 345.82M |
| June 30, 2024 | 392.68M |
| March 31, 2024 | 437.33M |
| December 31, 2023 | 473.58M |
| September 30, 2023 | 503.05M |
| June 30, 2023 | 533.06M |
| March 31, 2023 | 561.92M |
| December 31, 2022 | 313.34M |
| September 30, 2022 | 336.99M |
| June 30, 2022 | 147.79M |
| Date | Value |
|---|---|
| March 31, 2022 | 173.79M |
| December 31, 2021 | 199.06M |
| September 30, 2021 | 220.44M |
| June 30, 2021 | 243.98M |
| March 31, 2021 | 264.17M |
| December 31, 2020 | 283.06M |
| September 30, 2020 | 300.35M |
| June 30, 2020 | 315.82M |
| March 31, 2020 | 173.56M |
| December 31, 2019 | -0.435M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-0.435M
Minimum
Dec 2019
561.92M
Maximum
Mar 2023
310.97M
Average
306.84M
Median
Shareholders Equity (Quarterly) Benchmarks
| Haemonetics Corp | 878.85M |
| Marker Therapeutics Inc | 7.450M |
| Aligos Therapeutics Inc | 50.10M |
| Korro Bio Inc | 179.63M |
| CEL-SCI Corp | 8.473M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 445.66M |
| Total Liabilities (Quarterly) | 99.84M |